Module Details

Back to List

Volume 26   No. 4    October  2021    
Breaking Down New Drug Approvals and Biosimilars 2021
Learning Objectives

1. Define the following terms used in the FDA approval process: accelerated approval, breakthrough therapy, fast track, priority review.
2. Describe the main indications for new drugs approved by the US Food and Drug Administration.
3. Explain the formulation, dose, preparation, and route of administration of drugs reviewed.
4. Identify the following terms: biologic, biosimilar, reference product, bioequivalence, and interchangeability.
5. Discuss the key differences between biosimilars and generic medications.


Brittany Lee Karas, PharmD
Clinical Pharmacist, Drug Information
Northwestern Memorial Hospital
Chicago, IL

ACPE UAN 0121-0000-21-004-H01-T
Activity Type: Knowledge-based
Release date: October 1, 2021
Expiration date: September 30, 2024

This module will provide 2.5 contact hours (0.25 ceus) of continuing pharmacy education credit for pharmacy technicians.
UAN: 0121-0000-21-004-H01-T       2.5 Contact Hours        Type of Activity: Knowledge-based       10/1/2021 - 9/30/2024